Use of immunotherapy in the treatment of a patient with two simultaneous metastatic diseases
Liječnički vjesnik(2023)
摘要
Immunotherapy is an evolving and promising cancer treatment proven to significantly prolong survival in a multitude of oncological diseases. Nivolumab, a monoclonal antibody to the PD-1 receptor, is an immunotherapy used in the treatment of several cancers, including melanoma and renal cell carcinoma (RCC).
更多查看译文
关键词
Immunotherapy,Metastatic disease,Nivolumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要